Antimycobacterial activity of Pichia pastoris-derived mature bovine neutrophil β-defensins 5.
Tuberculosis (TB) is an ongoing threat to global health, and the lack of effective therapies for treating it is also a global problem. Previous studies have shown that human cathelicidin and defensins have effective antimicrobial activity against Mycobacterium spp. To our knowledge, there are no reports on the antimycobacterial effects of bovine neutrophil β-defensins so far. Here, we identified the antimicrobial effect of mature bovine neutrophil β-defensins (mBNBD) 5 against Mycobacterium infection both in vitro and in vivo. The mBNBD5 protein was expressed in Pichia pastoris. To increase the yield of β-defensins, a purification method was employed by adding a 6-His·tag to the C-terminus of the mBNBD5 gene. Our results indicated that recombinant mBNBD5 protein was successfully expressed and purified from Pichia pastoris with intact antimicrobial activity. The recombinant protein exhibited potent bactericidal activity in vitro against M. smegmatis and M. bovis, with a dose-dependent manner and a time-dependent manner. The electron microscope results showed that the bacterial cell wall of M. bovis was disrupted when incubated with mBNBD5 for 72 h. Our data also indicated that the exogenous addition of mBNBD5 could reduce the survival of Mycobacterium spp., especially M. tuberculosis and M. bovis in RAW 264.7 macrophages. These results provide foundations for the development of mBNBD5 as a potential new therapeutic agent for TB treatment.
The State Key Lab of Agrobiotechnology; Key Lab of Animal Epidemiology and Zoonosis, Ministry of Agriculture; National Animal Transmissible Spongiform Encephalopathy Laboratory; College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China, jjkang0206@gmail.com.
J
J
Kang
D
D
Zhao
Y
Y
Lyu
L
L
Tian
X
X
Yin
L
L
Yang
K
K
Teng
X
X
Zhou
D000818:Animals; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D002473:Cell Wall / Q000187:drug effects / Q000648:ultrastructure; D002846:Chromatography, Affinity; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression; D005822:Genetic Vectors; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D051379:Mice; D050296:Microbial Viability / Q000187:drug effects; D008854:Microscopy, Electron; D009163:Mycobacterium bovis / Q000187:drug effects*; D020102:Mycobacterium smegmatis / Q000187:drug effects*; D010843:Pichia / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics / Q000302:isolation & purification / Q000494:pharmacology; D013997:Time Factors; D023083:beta-Defensins / Q000235:genetics / Q000302:isolation & purification / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D011994:Recombinant Proteins; D023083:beta-Defensins